Home › GSK buys Swiss vaccine developer for $325M
 

Keywords :   


GSK buys Swiss vaccine developer for $325M

2013-05-29 18:43:57| Biotech - Topix.net

British pharma GlaxoSmithKline , which has its North American headquarters in Research Triangle Park, has acquired Swiss vaccine developer Okairos AG for about $325 million in cash.

Tags: developer swiss buys vaccine

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »